Showing results (111-120 of 165) with videos related to
Sort By:
Pageof 17
Implementation Research and Practice|April 3, 2026
Implementing a "Naloxone Hub With Many Spokes" Model in Kentucky: Partner Agency Perspectives on Implementation StrategiesHannah K Knudsen, Michael Goetz, Shaquita Andrews-Higgins, et al.The Journal of Continuing Education in the Health Professions|June 17, 2026
Development and Early Outcomes of Interprofessional Education on Opioid Use Disorder in the Kentucky HEALing Communities StudyChristopher D Cook, Katrina Nickels, John A Lauckner, et al.Psychopharmacology|June 9, 2021
Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans - pilot study outcomesShanna Babalonis, Sandra D Comer, Jermaine D Jones, et al.Journal of Substance Use and Addiction Treatment|May 13, 2024
Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changesLindsey R Hammerslag, Jeffery Talbert, Svetla Slavova, et al.Drug and Alcohol Dependence|December 23, 2003
Open-label trial of an injection depot formulation of buprenorphine in opioid detoxificationBai-Fang X Sobel, Stacey C Sigmon, Sharon L Walsh, et al.Therapeutic Advances in Infectious Disease|July 18, 2022
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infectionsLaura C Fanucchi, Sean M Murphy, Hilary Surratt, et al.Journal of Addiction Medicine|March 18, 2025
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation SettingHannah K Knudsen, Amanda Fallin-Bennett, Laura Fanucchi, et al.Journal of Substance Use and Addiction Treatment|February 24, 2025
The costs of peer recovery support services provided through two models within a recovery community centerDrew D Speer, Joshua L Bush, Don Lochana Ekanayake, et al.Journal of Addiction Medicine|April 10, 2024
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased MortalityFeitong Lei, Michelle R Lofwall, Jana McAninch, et al.Research Square|December 3, 2025
Analysis of the Costs and Reach of Transportation Services to Reduce Barriers to Opioid Use Disorder (OUD) Treatment: Evidence from the Kentucky HEALing Communities StudyDrew D Speer, Joshua L Bush, Don Lochana Ekanayake, et al.Pageof 17